US probing Moderna vaccine for higher heart inflammation risk
There might be a 2.5 times higher incidence of myocarditis in those who get the Moderna vaccine compared with Pfizer's vaccine20-08-2021
US probing Moderna vaccine for higher heart inflammation risk
There might be a 2.5 times higher incidence of myocarditis in those who get the Moderna vaccine compared with Pfizer's vaccineAs covid-19 boosters loom, Pfizer and Moderna expected to see billions more in sales
The spread of the Delta variant is increasing demand for messenger RNA vaccines and boosters, while the companies raise pricesPfizer submits data for 3rd dose approval in US
Pfizer and BioNTech presented the results of their Phase One trial that evaluated the safety and efficacy of a third shot.Israel begins COVID-19 booster shots for people over 50s
Israel was one of the first countries to launch a vaccination drive in mid-December via an agreement with Pfizer to obtain millions of paid doses in exchange for sharing data on their effectiveness.US FDA okays Covid booster dose for those with weak immune system
The US FDA authorised both the Pfizer-BioNTech and Moderna's Covid-19 vaccine to administer an additional dose in people with weaker immune systems, which includes organ transplant recipientsCOVID-19 | Moderna 76% effective against Delta variant, Pfizer 42%: Study
From January to June, the vaccines as claimed remained effective around 90 per cent, but began dipping in June and largely dropped in July as the variant took hold in the US.BioNTech says has supplied more than 1 billion Covid vaccine doses so far
BioNTech and partner Pfizer have supplied more than one billion doses of their vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca the German biotech Group saidCoronavirus LIVE: J&J; seeks approval for single shot vaccine in India
It is not clear whether, like Pfizer and Moderna, it is seeking indemnity against legal action that may arise from any side-effectsModerna says its Covid shot remains 93% effective 4-6 months after 2nd dose
That compares favorably to data released by rivals Pfizer Inc and BioNTech SE last weekWorld Coronavirus Dispatch: Researchers call for shots that target Delta
Ardern's popularity drops as New Zealand stumbles on vaccination, Pfizer may get full approval for its vaccine by September, and other pandemic-related news across the globe